Funds holding JUPITER NEUROSCIENCES INC
ISIN US48208B2034 · United States
- Fund holders
- 5
- Of which ETFs
- 0 5 other funds
- Value held
- 72.1K $
- Share of capital
- 39.3 % of 770.1K shares on Aug 14, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 128,042 | 27.4K $ | 16.63 % | as of Jun 30, 2026 ↗ | |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 124,487 | 31.9K $ | 0.00 % | 16.17 % | as of May 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 17,979 | 4.6K $ | 2.33 % | as of May 31, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 16,075 | 4.1K $ | 2.09 % | as of May 31, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 15,860 | 4.1K $ | 2.06 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 5 | -2 | 302,443 | -38.0 % |
| 2026Q2 | 7 | +1 | 487,499 | +68.4 % |
| 2026Q1 | 6 | +4 | 289,433 | +101.1 % |
| 2025Q4 | 2 | +1 | 143,902 | +1,385.5 % |
| 2025Q3 | 1 | -1 | 9,687 | -56.8 % |
| 2025Q2 | 2 | 22,407 |
Institutional managers
8 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| VESTOR CAPITAL, LLC | 970,985 | 365 $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 211,696 | 79.6K $ | as of Mar 31, 2026 |
| Yorkville Advisors Global, LP | 129,000 | 48.5K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 101,661 | 38.2K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 25,346 | 9.5K $ | as of Mar 31, 2026 |
| Virtu Financial LLC | 13,575 | 5 $ | as of Mar 31, 2026 |
| UBS Group AG | 3,928 | 1.5K $ | as of Mar 31, 2026 |
| MidFirst Bank | 1,000 | 376 $ | as of Mar 31, 2026 |
Declared shareholders of JUPITER NEUROSCIENCES INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| PharmAla Biotech Holdings Inc. | 17.30 % | 132,867 | as of Aug 20, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding JUPITER NEUROSCIENCES INC". https://titelia.com/en/stocks/jupiter-neurosciences-inc-US48208B2034